Determination of Red Cell Pyruvate Kinase

Introduction

  • Pyruvate kinase (PK) is a key glycolytic enzyme that catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate with the generation of adenosine triphosphate (ATP).
  • Since mature red blood cells (RBCs) lack mitochondria, glycolysis is their sole source of energy.
  • Therefore, pyruvate kinase plays a crucial role in maintaining RBC survival, membrane integrity, and normal cellular function.
  • Deficiency of red cell pyruvate kinase is one of the most common inherited defects of glycolysis and can lead to chronic non-spherocytic hemolytic anemia.
  • Measurement of pyruvate kinase activity in erythrocytes is therefore important in the diagnosis of PK deficiency.

Principle

Pyruvate kinase catalyzes the following reaction:

PEP + ADP → Pyruvate + ATP

The pyruvate formed is immediately converted to lactate by lactate dehydrogenase (LDH) in the presence of NADH:

Pyruvate + NADH + H⁺ → Lactate + NAD⁺

NADH absorbs ultraviolet light at 340 nm, whereas NAD⁺ does not. The decrease in absorbance at 340 nm due to oxidation of NADH is directly proportional to pyruvate kinase activity in the red cell hemolysate.


Specimen Required

  • Fresh EDTA anticoagulated whole blood
  • Red blood cells separated and washed with isotonic saline
  • Hemolysate prepared from packed RBCs

Sample Precautions

  • Avoid hemolysis during collection.
  • Analyze as soon as possible.
  • Store at 2–8°C if delay is unavoidable.
  • Excessive storage may reduce enzyme activity.

Reagents

  1. Tris buffer (pH 7.5–7.8)
  2. Magnesium chloride (MgCl₂)
  3. Potassium chloride (KCl)
  4. Adenosine diphosphate (ADP)
  5. Phosphoenolpyruvate (PEP)
  6. Nicotinamide adenine dinucleotide, reduced form (NADH)
  7. Lactate dehydrogenase (LDH)
  8. Distilled water

Procedure

Preparation of Red Cell Hemolysate

  1. Collect 2–3 mL of venous blood in an EDTA tube.
  2. Centrifuge the sample at 1500–2000 rpm for 10 minutes.
  3. Carefully remove the plasma and buffy coat (white cell layer).
  4. Wash the packed red blood cells three times with isotonic saline (0.9% NaCl).
  5. After the final wash, prepare a hemolysate by lysing the erythrocytes with distilled water according to the laboratory protocol.
  6. Determine the hemoglobin concentration of the hemolysate for subsequent calculation of enzyme activity.

Assay Procedure

  1. Label a cuvette for the test sample.
  2. Pipette the required volume of reaction mixture containing:
    • Tris buffer
    • Magnesium chloride (MgCl₂)
    • Potassium chloride (KCl)
    • ADP
    • NADH
    • Lactate dehydrogenase (LDH)
  3. Add the prepared red cell hemolysate to the reaction mixture and mix gently.
  4. Incubate the mixture at 37°C for 5 minutes.
  5. Add phosphoenolpyruvate (PEP) to initiate the reaction.
  6. Immediately record the absorbance at 340 nm using a UV spectrophotometer.
  7. Measure the absorbance at 1-minute intervals for 3–5 minutes.
  8. Calculate the average decrease in absorbance per minute (ΔA/min).

Observation

A gradual decrease in absorbance at 340 nm is observed due to oxidation of NADH to NAD⁺. The rate of decrease is directly proportional to the pyruvate kinase activity present in the red cell hemolysate.


Calculation

Pyruvate kinase activity is generally expressed as:

  • Units per gram hemoglobin (U/g Hb)
  • Units per 10¹⁰ erythrocytes

General formula:

PK Activity = ΔA/min × Factor

The factor depends on:

  • Path length
  • Total reaction volume
  • Sample volume
  • Molar absorptivity of NADH

Reference Values

Typical adult values:

Parameter Reference Range
Red Cell Pyruvate Kinase 8–18 U/g Hb

Reference ranges may vary according to laboratory methods and assay kits.


Interpretation

Normal Result

Indicates adequate glycolytic activity and ATP generation in erythrocytes.

Low Result

Suggests:

  • Pyruvate kinase deficiency
  • Chronic hemolytic anemia
  • Enzyme instability disorders

High Result

May occur due to:

  • Increased reticulocyte count
  • Compensatory erythropoiesis

Advantages

  • Early Detection of Pyruvate Kinase Deficiency
    • Helps identify hereditary pyruvate kinase deficiency, one of the most common glycolytic enzyme defects causing chronic hemolytic anemia.
  • Accurate Assessment of Enzyme Activity
    • Directly measures the functional activity of pyruvate kinase in erythrocytes, providing reliable diagnostic information.
  • Useful in the Evaluation of Hemolytic Anemia
    • Assists in investigating unexplained chronic hemolytic anemia, particularly when other common causes have been excluded.
  • Sensitive and Specific Method
    • The coupled enzymatic assay using NADH oxidation is highly sensitive and capable of detecting even moderate reductions in enzyme activity.
  • Quantitative Results
    • Provides precise numerical values that can be compared with reference ranges and used for clinical interpretation.
  • Requires Only a Small Blood Sample
    • Can be performed using a relatively small volume of EDTA-anticoagulated blood.
  • Rapid and Reproducible
    • The spectrophotometric method is simple, rapid, and produces reproducible results when performed under standardized conditions.
  • Useful for Family Screening
    • Can aid in the investigation of family members of affected individuals in inherited pyruvate kinase deficiency.
  • Supports Clinical Decision-Making
    • Helps clinicians differentiate pyruvate kinase deficiency from other causes of hereditary hemolytic anemia.
  • Suitable for Routine Clinical Laboratories
    • Can be performed using standard UV-visible spectrophotometric equipment available in most clinical biochemistry laboratories.

Limitations

  • Effect of Recent Blood Transfusion
    • Transfused donor red blood cells may contain normal pyruvate kinase activity, leading to falsely normal or elevated results and masking an underlying deficiency.
  • Influence of Reticulocytosis
    • Reticulocytes contain higher levels of pyruvate kinase than mature erythrocytes.
    • Patients with increased reticulocyte counts may show falsely elevated enzyme activity.
  • Sample Stability Issues
    • Pyruvate kinase activity decreases during prolonged storage.
    • Delayed analysis or improper sample handling can result in falsely low values.
  • Cannot Identify Genetic Mutations
    • The enzyme assay measures functional activity but does not determine the specific genetic mutation responsible for pyruvate kinase deficiency.
    • Molecular testing may be required for confirmation.
  • Overlap Between Normal and Carrier States
    • Some heterozygous carriers may have enzyme activities within the normal range, making carrier detection difficult.
  • Interference from Leukocyte Contamination
    • Incomplete removal of white blood cells during sample preparation may affect enzyme measurements and lead to inaccurate results.
  • Requires Fresh Blood Samples
    • Freshly collected EDTA blood is preferred because enzyme activity may decline during storage.
  • Limited Diagnostic Value Alone
    • Results should always be interpreted along with clinical findings, peripheral smear examination, reticulocyte count, and other hematological investigations.
  • Specialized Equipment Required
    • The assay requires a UV spectrophotometer capable of measuring absorbance at 340 nm, which may not be available in all laboratories.
  • May Miss Mild Deficiency
    • Patients with mild enzyme deficiency may have enzyme activities near the lower limit of normal, making diagnosis challenging without additional testing.

Clinical Applications

1. Diagnosis of Hereditary Pyruvate Kinase Deficiency

  • The principal application of the test is the diagnosis of hereditary pyruvate kinase deficiency, an autosomal recessive disorder characterized by reduced ATP production in red blood cells.
  • It helps confirm the diagnosis in patients presenting with chronic hemolytic anemia, jaundice, and splenomegaly.

2. Evaluation of Chronic Hemolytic Anemia

  • Useful in investigating patients with unexplained chronic hemolytic anemia when common causes such as autoimmune hemolytic anemia, hemoglobinopathies, and membrane defects have been excluded.

3. Investigation of Neonatal Jaundice

  • Pyruvate kinase deficiency may present in newborns with severe jaundice and anemia.
  • Measurement of enzyme activity aids in identifying an underlying enzymatic defect.

4. Differential Diagnosis of Hereditary Hemolytic Disorders

  • Helps differentiate pyruvate kinase deficiency from other inherited red cell disorders such as:
    • G6PD deficiency
    • Hereditary spherocytosis
    • Other erythrocyte enzyme deficiencies

5. Family Screening and Genetic Counseling

  • Family members of affected individuals may be screened for enzyme abnormalities.
  • Results can support genetic counseling in families with a history of pyruvate kinase deficiency.

6. Assessment of Erythrocyte Metabolic Disorders

  • The test is valuable in evaluating rare disorders of red cell glycolysis and energy metabolism.

7. Pre-Molecular Diagnostic Evaluation

  • Enzyme activity measurement is often performed before genetic testing and helps identify patients who may benefit from molecular analysis of the PKLR gene.

8. Monitoring Patients with Known Enzyme Deficiency

  • In selected cases, enzyme activity assessment may be used as part of the clinical evaluation and follow-up of patients with diagnosed pyruvate kinase deficiency.

9. Research Applications

  • Widely used in hematology and biochemical research to study erythrocyte metabolism, glycolytic pathways, and inherited enzyme disorders.

10. Educational and Laboratory Training Purposes

  • Serves as an important practical assay for teaching enzyme kinetics, coupled enzyme reactions, and spectrophotometric methods in clinical biochemistry laboratories.
Scroll to Top
Enable Notifications OK No thanks